Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Inventory Average (2019 - 2025)

10x Genomics (TXG) has disclosed Inventory Average for 7 consecutive years, with $59.1 million as the latest value for Q4 2025.

  • Quarterly Inventory Average fell 33.22% to $59.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $59.1 million through Dec 2025, down 33.22% year-over-year, with the annual reading at $69.7 million for FY2025, 11.07% down from the prior year.
  • Inventory Average hit $59.1 million in Q4 2025 for 10x Genomics, down from $65.5 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $91.2 million in Q3 2024 to a low of $34.2 million in Q1 2021.
  • Historically, Inventory Average has averaged $70.3 million across 5 years, with a median of $76.0 million in 2022.
  • Biggest five-year swings in Inventory Average: soared 103.15% in 2021 and later tumbled 33.22% in 2025.
  • Year by year, Inventory Average stood at $55.6 million in 2021, then skyrocketed by 44.24% to $80.1 million in 2022, then decreased by 3.52% to $77.3 million in 2023, then increased by 14.57% to $88.6 million in 2024, then crashed by 33.22% to $59.1 million in 2025.
  • Business Quant data shows Inventory Average for TXG at $59.1 million in Q4 2025, $65.5 million in Q3 2025, and $71.8 million in Q2 2025.